← All Vivani Medical, INC filings

Vivani Medical, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
VANI
Vivani Medical, INC
10-K: Vivani Medical Advances GLP-1 Implants, Reports 2025 Losses
Vivani Medical, Inc. reported a net loss of $26.6 million in 2025 while advancing its NanoPortal GLP-1 implant programs and securing significant capital.
NASDAQ
VANI
Vivani Medical, INC
10-K: Vivani Medical's 10-K Filing: Prioritizing Obesity Portfolio and Advancing Clinical Trials
Vivani Medical's 10-K filing highlights the company's focus on its obesity portfolio, progress in clinical trials, and financial activities including securities offerings and a potential Cortigent spin-off.
NASDAQ
VANI
Vivani Medical, INC
10-K: Vivani Medical Prioritizes Obesity Portfolio, Reports Positive Preclinical Data
Vivani Medical shifts focus to obesity treatments, showcasing promising preclinical results for its NPM-115 implant.